Telmisartan/Amlodipine Besylate/Hydrochlorothiazide

替米沙坦/苯磺酸氨氯地平/氢氯噻嗪

Report date: 2026/03/23 20:03:44

Base Information

Drug NameTelmisartan/Amlodipine Besylate/Hydrochlorothiazide
Drug Alias NameTelmisartan - amlodipine - hydrochlorothiazide mixt苯磺酸氨氯地平/替米沙坦/氢氯噻嗪苯磺酸氨氯地平/氢氯噻嗪/替米沙坦Amlodipine Besilate/Hydrochlorothiazide/TelmisartanAmlodipine Besylate/Hydrochlorothiazide/Telmisartan +[10] 
ClassificationSmall molecules
Mechanisms of ActionAngiotensin II Receptor Type 1 antagonistsVoltage-gated calcium channel blockersThiazide-sensitive sodium-chloride cotransporter inhibitors
TargetsThiazide-sensitive sodium-chloride cotransporterAngiotensin II Receptor Type 1Voltage-gated calcium channel
Therapy Area/IndicationsHypertension
Global Approved IndicationsHypertension
Approved Indications in ChinaN/A
Original Approved Country/TerritoryJapan
Original Approved Date2016/09/28
Country/TerritoryJapan
CombinationsYes HydrochlorothiazideAmlodipine BesylateTelmisartan
Global Highest StatusApproved
Highest Status in ChinaN/A
Originator CompaniesC.H. Boehringer Sohn Ag & Co. Kg
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesC.H. Boehringer Sohn Ag & Co. Kg
Active IndicationsHypertension
Inactive IndicationsN/A

Other Information

ATC CodeC03AX01C09DA07
Related LinksKEGG